Font Size: a A A
Keyword [Molecular modeling]
Result: 81 - 100 | Page: 5 of 6
81. Design,Synthesis,Biological Evaluation And Molecular Modeling Of Novel 1H-pyrazolo[3,4-d] Pyrimidine Derivatives As BRAFV600E And VEGFR-2 Dual Inhibitors
82. Design,Synthesis,Biological Evaluation And Molecular Modeling Of 2-amino-4-oxo-6-substituted-Pyrrolo[2,3-d] Pyrimidines
83. Study On The Intermolecular Interaction Of HIV-1 Protease Inhibitors With Biomacromolecules
84. Study On The Construction And Application Of Molecular Modeling For HDAC And PP1 Inhibitors
85. The Molecular Modeling And Experimental Studies Of The Influences Of Graphene On The Structure And Fucntion Of Prion
86. Design,synthesis,biological Evaluation,and Molecular Modeling Of Aminopyridine Derivatives As ROS1 Kinase Inhibitors
87. Molecular Modeling Study Of Conformational Transition Mechanism Of Prion Protein And Peptide Inhibitor Design
88. Investigations Of The Interaction Between Small Molecule Compounds And Human Serum Albumin By Spectroscopic And Molecular Modeling Methods
89. Design,Synthesis,Biological Evaluation And Molecular Modeling Of Novel Classical And Non-Classical Folic Acid Antagonists
90. Computational Molecular Modeling Studies of the Interactions of Estrogens with Their Receptors and Intracellular Binding Protein PDIp
91. Molecular modeling and docking analysis of the variable regions of an anti-N6-methyladenosine monoclonal antibody
92. SCFA-hexosamines: Understanding anti-cancer mechanisms through chemical biology and molecular modeling
93. Platinum-based DNA binding agents as telomerase inhibitors and cancer therapeutics
94. Lesion bypass by human DNA polymerase iota: Molecular modeling and dynamics simulations of a Y-family polymerase
95. Investigating the stereoselectiviy of antibodies using molecular modeling
96. Identification & Evaluation of DNA Ligase Inhibitors: Predicting the Binding of Small Molecules to the DNA Binding Domain by Molecular Modeling
97. Design, synthesis, biological evaluation and molecular modeling of novel taxane-based anticancer agents and paclitaxel mimics
98. Design and synthesis of core structural intermediates for novel HIV-1 protease inhibitors and synthesis, biological activity and molecular modeling of novel 20S proteasome inhibitors
99. EPR and molecular modeling studies on nitroxide-labeled nucleic acids and reverse transcriptase systems
100. Design, synthesis, molecular modeling, and biological evaluation of novel NOP (nociceptin/orphanin FQ peptide) receptor ligands
  <<First  <Prev  Next>  Last>>  Jump to